MOHAMMED N AL HALLAK to Female
This is a "connection" page, showing publications MOHAMMED N AL HALLAK has written about Female.
Connection Strength
0.013
-
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy. Cancer Res Commun. 2024 10 01; 4(10):2598-2609.
Score: 0.007
-
The phase I/II eNRGy trial: Zenocutuzumab in?patients with cancers harboring NRG1 gene fusions. Future Oncol. 2024; 20(16):1057-1067.
Score: 0.006